U.S. Physical Therapy, Inc.

NYSE:USPH

Medical - Care Facilities

Healthcare
$95.43 +0.19%

+$0.12 today

Market cap
$1.42B
Beta
1.16
P/E (TTM)
810.7
EPS (TTM)
$0.08
Dividend yield
2.89%
52W Low $58.19High $93.50

Volume 0.33M

Average 0.20M

USPH Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

U.S. Physical Therapy, Inc.NYSE: USPH

Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026

Cost of revenue growth accelerates

Q1 FY2026 cost of revenue of $169.6M rose 39.6% year over year, ahead of the +7.3% change in trailing-twelve-month cost of revenue. Sequentially, it rose 5.4% from the prior quarter. Over 3 fiscal years it compounded at +12.2% a year.

Context

  • Cost of revenue amounted to 79.9% of revenue in FY2025, down 1.7 pp from a year earlier.
  • Cost of revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +39.6% holds above the trailing-twelve-month pace of +7.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$169.6M+5.4% QoQ
Last fiscal yearDec 2025
$623.65M+13.9% YoY
LTMMar 2026
$580.17M+7.3% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+39.6%——
1 year+13.9%——
3-year CAGR+12.2%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
623.65M USD
Year-over-year change
+13.9%
4-year CAGR
+13.3%

Cost of Revenue vs competitors

How USPH compares with its peers on the latest reported figures

  • USPH's LTM Mar 2026 cost of revenue of $580.17M is the 7th highest of the 11 companies compared; the peer median is $754.42M.
  • Its year-over-year change of +7.3% is the 9th highest of 11, against a peer median of +25.9%.
  • Cost of revenue amounts to 79.6% of revenue for USPH, versus a peer median of 85.2%.
USPH Competitors Peer median
Cost of Revenue for USPH and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SEMSelect Medical Holdings CorporationLTM Mar 2026$4.93B +28.0%-4.9%89.4%
ASTHAstrana Health, Inc.LTM Mar 2026$3.2B +61.8%+45.1%90.7%
AHCOAdaptHealth Corp.LTM Apr 2026$2.71B +8.1%+1.6%94.6%
HCSGHealthcare Services Group, Inc.LTM Mar 2026$1.6B +6.1%+2.2%86.4%
PNTGThe Pennant Group, Inc.LTM Mar 2026$871.95M +35.1%+25.8%85.2%
CNMDCONMED CorporationLTM Mar 2026$636.88M +8.8%+11.0%46.4%
USPHU.S. Physical Therapy, Inc.LTM Mar 2026$580.17M +7.3%+12.2%79.6%
NEOGNeogen CorporationLTM Aug 2026$465.01M -11.0%+3.5%52.6%
GDRXGoodRx Holdings, Inc.LTM Mar 2026$105.91M +115.7%-4.0%13.4%
ZBIOZenas BioPharma, Inc.LTM Mar 2026$103.75M +54.1%——
KMTSKestra Medical Technologies, Ltd.LTM Jan 2026$42.91M +23.8%—51.2%
Peer median (excluding USPH) $754.42M+25.9%+2.9%85.2%

Competitors are the stored peer set for USPH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue495.02M553.14M604.8M671.35M780.99M
Cost of Revenue377.84M441.12M483.29M547.42M623.65M
Gross Profit117.18M112.02M121.51M123.92M157.34M
Gross Margin23.7%20.3%20.1%18.5%20.1%
Research & Development00000
Selling, General & Admin46.53M46.11M058.29M0
Operating Expenses46.53M55.22M69.45M60.71M76.91M
Depreciation & Amortization11.59M14.74M15.7M18.68M22.39M
EBITDA85.73M76.09M74.37M86.91M109.66M
EBITDA Margin17.3%13.8%12.3%12.9%14.0%
Operating Income70.65M56.8M52.06M63.21M80.43M
Operating Margin14.3%10.3%8.6%9.4%10.3%
Interest Income003.77M3.94M105K
Interest Expense942K5.78M9.3M8.02M9.46M
Other Income / Expenses2.55M(1.23M)(2.69M)(3M)(2.62M)
Income Before Tax73.2M55.57M49.38M60.21M77.81M
Pre-Tax Margin14.8%10.0%8.2%9.0%10.0%
Income Tax Expense15.27M12.16M12.16M14.61M19.81M
Net Income27.82M28.27M14.67M26.46M15.06M
Net Margin5.6%5.1%2.4%3.9%1.9%
EPS (Basic)4.493.341.281.841.42
EPS (Diluted)4.493.341.281.841.42
Weighted Avg Shares12.9M12.99M14.19M15.06M15.18M
Weighted Avg Shares (Diluted)12.9M12.99M14.19M15.06M15.18M

U.S. Physical Therapy, Inc.

NYSE:USPH

Intrinsic Alpha fair value

Locked

Current Price

$95.43

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.